PLoS ONE (Jan 2022)

COVID-19 vaccine: A 2021 analysis of perceptions on vaccine safety and promise in a U.S. sample.

  • Vitalis C Osuji,
  • Eric M Galante,
  • David Mischoulon,
  • James E Slaven,
  • Gerardo Maupome

DOI
https://doi.org/10.1371/journal.pone.0268784
Journal volume & issue
Vol. 17, no. 5
p. e0268784

Abstract

Read online

BackgroundDespite reliable evidence-based research supporting the COVID-19 vaccines, population-wide confidence and trust remain limited. We sought to expand prior knowledge about COVID-19 vaccine perceptions, while determining which population groups are at greatest risk for not getting a vaccine.MethodsStudy participants in the U.S. (79% female, median age group 46-60 years) were recruited through an online Qualtrics survey distributed as a Facebook advertisement from 3/19/21-4/30/21. We assumed that every participant is at risk of COVID-19 infection and should be able to get the vaccine with proper access. Bivariate and multivariable models were performed. Collinearity between variables was assessed.ResultsA total of 2,626 responses were generated and 2,259 were included in data analysis. According to our multivariate model analysis, vaccines were perceived as safe by those who had or planned to obtain full vaccination (adjusted odds ratio (aOR) (95% confidence interval) = 40.0 (19.0, 84.2); pConclusionLevel of education and partisanship, but not race/ethnicity, were the most likely factors associated with vaccine hesitancy or likelihood to vaccinate. Also, low vaccination rates among underrepresented minorities may be due to distrust for healthcare industries. Population sub-groups less likely to be vaccinated and/or receptive to vaccines should be targeted for vaccine education and incentives.